Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116595 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Lea Jessica Albrecht und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Essen, Essen and German Cancer Consortium, partner site Essen and National Center for Tumor Diseases (…. Hauptthemen laut MEDLINE: Melanoma, Phenylurea Compounds, Quinolines, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität Duisburg-Essen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Essen, Essen and German Cancer Consortium, partner site Essen and National Center for Tumor Diseases (NCT), NCT-West, Campus Essen and University Alliance Ruhr, Research Ce…
- Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germa…
- Department of Dermatology, Elbe Hospital, Buxtehude, Germany.
- Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the National Center for Tumor Diseases and University Can…
- Department of Dermatology, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Department of Dermatology and Allergology, LMU University Hospital Munich, Ludwig-Maximilian University, Munich, Germany; Department of Dermatology, Uniklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlange…
Förderung
- Universität Duisburg-Essen
Zitieren
APA
Albrecht, L. J., Garnier, J., Zaremba, A., Brauch, L., Brunnert, F., Rauschenberg, R., Forschner, A., Vazquez, X. G., Mangana, J., Erdmann, M., Angela, Y., Franklin, C., Tietze, J., Lodde, G., Tasdogan, A., Seier, J. A., Roesch, A., Ugurel, S., Berking, C., …, & Zimmer, L. (2026). Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116595
Vancouver
Albrecht LJ, Garnier J, Zaremba A, Brauch L, Brunnert F, Rauschenberg R, et al. Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116595
BibTeX
@article{Albrecht2026,
author = {Albrecht, Lea Jessica and Garnier, Jana and Zaremba, Anne and Brauch, Lisa and Brunnert, Fiona and Rauschenberg, Ricarda and Forschner, Andrea and Vazquez, Xiomara Garza and Mangana, Joanna and Erdmann, Michael and Angela, Yenny and Franklin, Cindy and Tietze, Julia and Lodde, Georg and Tasdogan, Alpaslan and Seier, Johanna A and Roesch, Alexander and Ugurel, Selma and Berking, Carola and Gutzmer, Ralf and Heinzerling, Lucie and Meier, Friedegund and Mohr, Peter and Hassel, Jessica C and Schadendorf, Dirk and Livingstone, Elisabeth and Zimmer, Lisa},
title = {Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116595}
}
EUVIMED